181 related articles for article (PubMed ID: 10616204)
21. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
22. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
23. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
24. Context matters: the hen or egg problem in Ewing's sarcoma.
Kovar H
Semin Cancer Biol; 2005 Jun; 15(3):189-96. PubMed ID: 15826833
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.
Olsen RJ; Hinrichs SH
Oncogene; 2001 Mar; 20(14):1756-64. PubMed ID: 11313922
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
27. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
28. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product.
Zhang PJ; Goldblum JR; Pawel BR; Fisher C; Pasha TL; Barr FG
Mod Pathol; 2003 Mar; 16(3):229-35. PubMed ID: 12640103
[TBL] [Abstract][Full Text] [Related]
30. The EWS protein is dispensable for Ewing tumor growth.
Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
[TBL] [Abstract][Full Text] [Related]
31. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.
Arvand A; Welford SM; Teitell MA; Denny CT
Cancer Res; 2001 Jul; 61(13):5311-7. PubMed ID: 11431376
[TBL] [Abstract][Full Text] [Related]
32. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
[TBL] [Abstract][Full Text] [Related]
34. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
[TBL] [Abstract][Full Text] [Related]
35. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
Lee SB; Kolquist KA; Nichols K; Englert C; Maheswaran S; Ladanyi M; Gerald WL; Haber DA
Nat Genet; 1997 Nov; 17(3):309-13. PubMed ID: 9354795
[TBL] [Abstract][Full Text] [Related]
36. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma.
Kaneko Y; Kobayashi H; Handa M; Satake N; Maseki N
Genes Chromosomes Cancer; 1997 Mar; 18(3):228-31. PubMed ID: 9071576
[TBL] [Abstract][Full Text] [Related]
37. The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide.
Lawlor ER; Lim JF; Tao W; Poremba C; Chow CJ; Kalousek IV; Kovar H; MacDonald TJ; Sorensen PH
Cancer Res; 1998 Jun; 58(11):2469-76. PubMed ID: 9622091
[TBL] [Abstract][Full Text] [Related]
38. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
May WA; Denny CT
Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
[No Abstract] [Full Text] [Related]
39. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
Deneen B; Denny CT
Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]